{
  "name": "IRT system test and control expectations: EMA computerised-systems guideline mapped to ICH E6(R3)",
  "description": "Cross-walk compiled from two regulatory guidelines: for each IRT function, the testing or control expectation in EMA Annex 5 (A5.2) and related annexes, and the matching ICH E6(R3) section. Rows with no counterpart are marked with a dash.",
  "page": "https://casrai.org/guides/irt-system",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-20T19:58:04Z",
  "temporalCoverage": "2023/2025",
  "spatialCoverage": null,
  "columns": [
    {
      "name": "IRT function",
      "unit": "",
      "description": ""
    },
    {
      "name": "EMA guideline expectation",
      "unit": "",
      "description": ""
    },
    {
      "name": "EMA clause",
      "unit": "",
      "description": ""
    },
    {
      "name": "ICH E6(R3) counterpart",
      "unit": "",
      "description": ""
    }
  ],
  "rows": [
    {
      "IRT function": "Trial-specific configuration",
      "EMA guideline expectation": "Portal customisation must be consistent with the approved protocol and robustly tested, e.g. randomisation strata and dose calculations",
      "EMA clause": "Section on customisation of portals and Annex 2 (A2.3-A2.6)",
      "ICH E6(R3) counterpart": "4.3.4: standard functionality and protocol-specific configurations validated before use"
    },
    {
      "IRT function": "Dose assignment",
      "EMA guideline expectation": "Verify look-up tables against the protocol; test borderline values between doses; incorrect dosing is a significant safety risk",
      "EMA clause": "Annex 5, A5.2",
      "ICH E6(R3) counterpart": "4.3.4: automated checks and calculations validated"
    },
    {
      "IRT function": "Stratified randomisation",
      "EMA guideline expectation": "Test all combinations of strata to confirm allocation from the correct randomisation table",
      "EMA clause": "Annex 5, A5.2",
      "ICH E6(R3) counterpart": "2.11: randomisation procedures followed"
    },
    {
      "IRT function": "Access to unblinded information",
      "EMA guideline expectation": "Provide only to pre-identified user roles",
      "EMA clause": "Annex 5, A5.2; Annex 3 (user management)",
      "ICH E6(R3) counterpart": "4.1: sponsor staff and providers have no unblinding access unless justified by design"
    },
    {
      "IRT function": "Emergency unblinding",
      "EMA guideline expectation": "Test the process, keep a backup if the online route is unavailable, verify site ability before IMP is administered",
      "EMA clause": "Annex 5, A5.2",
      "ICH E6(R3) counterpart": "2.11: investigator able to unblind without undue delay; premature unblinding documented"
    },
    {
      "IRT function": "Unplanned unblinding",
      "EMA guideline expectation": "Not stated as a separate item in A5.2",
      "EMA clause": "-",
      "ICH E6(R3) counterpart": "4.1: document any unblinding and assess impact on trial results"
    },
    {
      "IRT function": "Clinical data captured in IRT",
      "EMA guideline expectation": "Source data verification and/or reconciliation with the data acquisition tool; E6 data-acquisition requirements in IRT requirements and UAT",
      "EMA clause": "Annex 5, A5.2",
      "ICH E6(R3) counterpart": "4.3.4: interfaces between systems defined and validated"
    },
    {
      "IRT function": "Web-based randomisation lists",
      "EMA guideline expectation": "Document suitability, GCP compliance and fitness for purpose; keep service version and seed; ad hoc web randomisation not recommended",
      "EMA clause": "Annex 5, A5.2",
      "ICH E6(R3) counterpart": "-"
    },
    {
      "IRT function": "Reconstruction of randomisation",
      "EMA guideline expectation": "Process reconstructable from retained documentation and data; final randomisation schedule retained",
      "EMA clause": "Annex 5, A5.2",
      "ICH E6(R3) counterpart": "-"
    }
  ],
  "sources": [
    {
      "title": "EMA Guideline on computerised systems and electronic data in clinical trials (EMA/INS/GCP/112288/2023)",
      "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guideline-computerised-systems-electronic-data-clinical-trials_en.pdf",
      "accessed": "2026-11-20"
    },
    {
      "title": "ICH E6(R3) Guideline for Good Clinical Practice",
      "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e6r3-guideline-good-clinical-practice-step-5_en.pdf",
      "accessed": "2026-11-20"
    }
  ]
}